Clinical Applications of The Cancer Genome Atlas Project (TCGA) for Squamous Cell Lung Carcinoma

被引：0

作者：

Devarakonda, Siddhartha ^{[1
]}

Morgensztern, Daniel ^{[2
]}

Govindan, Ramaswamy ^{[2
]}

机构：

[1] St Lukes Hosp, Dept Internal Med, Chesterfield, MO USA

[2] Washington Univ, Sch Med, Div Med Oncol, St Louis, MO USA

来源：

ONCOLOGY-NEW YORK | 2013年 / 27卷 / 09期

关键词：

FACTOR RECEPTOR MUTATIONS; TRANSCRIPTION FACTOR NRF2; PHASE-II; 1ST-LINE TREATMENT; CHEMONAIVE PATIENTS; 3Q AMPLIFICATION; 3RD-LINE THERAPY; STEM-CELLS; OPEN-LABEL; GROWTH;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Very little progress has been made in the treatment of patients with metastatic squamous cell lung cancer over the past 2 decades. Identification of novel molecular alterations for targeted therapies is necessary to improve outcomes. Advances in genomic technology have now made it possible to analyze the genomic landscape of tumor tissues comprehensively. We summarize here key findings from the comprehensive analysis of squamous cell lung cancer by The Cancer Genome Atlas group and discuss the clinical implications of these findings.

引用

页码：899 / 906

页数：8

共 50 条

[31] Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): results from The Cancer Genome Atlas (TCGA) [J].

Danaher, Patrick ;

Warren, Sarah ;

Lu, Rongze ;

Samayoa, Josue ;

Sullivan, Amy ;

Pekker, Irena ;

Wallden, Brett ;

Marincola, Francesco M. ;

Cesano, Alessandra .

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6

[32] A computational study of gene expression patterns in head and neck squamous cell carcinoma using TCGA data [J].

Rauf, Saqib ;

Ullah, Sami ;

Abid, Muhammad Adil ;

Ullah, Asad ;

Khan, Gullzar ;

Khan, Ainee Urooj ;

Ahmad, Gulzar ;

Ijaz, Muhammad ;

Ahmad, Sidra ;

Faisal, Sulaiman .

FUTURE SCIENCE OA, 2024, 10 (01)

[33] Clinical significance of SPARC in esophageal squamous cell carcinoma [J].

Chen, Yelong ;

Zhang, Ying ;

Tan, Yang ;

Liu, Zhaoyong .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 492 (02) :184-191

[34] Differential expression of sonic hedgehog in lung adenocarcinoma and lung squamous cell carcinoma [J].

Xu, L. ;

Xiong, H. ;

Shi, W. ;

Zhou, F. ;

Zhang, M. ;

Hu, G. ;

Mei, J. ;

Luo, S. ;

Chen, L. .

NEOPLASMA, 2019, 66 (05) :839-846

[35] Association of Diabetes Severity and Mortality with Lung Squamous Cell Carcinoma [J].

Su, Chih-Hsiung ;

Chen, Wan-Ming ;

Chen, Mingchih ;

Shia, Ben-Chang ;

Wu, Szu-Yuan .

CANCERS, 2022, 14 (10)

[36] Clinical Value and Potential Mechanism of miRNA-33a-5p in Lung Squamous Cell Carcinoma [J].

Wang, Xiang-Ming ;

Chen, Shang-Wei ;

Chen, Gang ;

Zhou, Hua-Fu ;

Gan, Ting-Qing ;

Zeng, Jing-Jing ;

Li, Zu-Yun .

ANALYTICAL CELLULAR PATHOLOGY, 2021, 2021

[37] A prognostic model of non small cell lung cancer based on TCGA and ImmPort databases [J].

Yang, Dongliang ;

Ma, Xiaobin ;

Song, Peng .

SCIENTIFIC REPORTS, 2022, 12 (01)

[38] Clinical applications of circulating biomarkers in non-small cell lung cancer [J].

Oh, Hyun-Ji ;

Imam-Aliagan, Abdulhamid B. ;

Kim, Yeo-Bin ;

Kim, Hyun-Jin ;

Izaguirre, Issac A. ;

Sung, Chang K. ;

Yim, Hyungshin .

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2024, 12

[39] Preclinical and clinical development of afatinib: a focus on breast cancer and squamous cell carcinoma of the head and neck [J].

Harbeck, Nadia ;

Solca, Flavio ;

Gauler, Thomas C. .

FUTURE ONCOLOGY, 2014, 10 (01) :21-40

[40] Unusual presentation of a recurrent squamous cell lung cancer [J].

Cakir, H. ;

Ocal, L. ;

Ocal, A. G. ;

Cakir, H. ;

Akkus, E. E. ;

Kahveci, G. .

QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2015, 108 (03) :231-232

← 1 2 3 4 5 →